RHOBTB2 promoter methylation appears to associate with more advanced tumor stages [25] or a particular status, like the presence of p53 mutation, HER2-positive status [25], or progesterone receptor negative status [36]. This evidence concerns the gene RHOBTB2 and neoplasm.